Press Trust of India on MSN
Biocon receives GST demand notice of over Rs 3.2 cr
New Delhi, Oct 10 (PTI) Biotechnology major Biocon Ltd on Saturday said it has received a GST demand notice of over Rs 3 ...
Biocon’s Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA’s Tailored Clinical Approach
On September 22, 2026, Biocon Biologics Limited (“Biocon”) announced that the European Medicines Agency’s (“EMA”) Committee for Medicinal Products ...
Biocon stock offers investors exposure to a diversified biopharmaceutical business that generated 4,336.0 crore rupees of ...
Biocon jumped nearly 3% in Monday's trade after the company's Pertuzumab biosimilar drug received EMA CHMP recommendation for breast cancer care.
Biocon shares gained as much as 3 percent after a Rs 635-crore block deal, while the company said its biosimilars business could soon reach $1 billion in revenue.
Biocon’s pertuzumab is the first biosimilar to secure EMA CHMP approval recommendation under a new tailored clinical approach.
Within four months of kick-starting a corporate commuter nudge programme, more than 1,500 employees of Hebbagodi-based ...
Peter Bains is vacating his seat on the Biocon board to take on the role of chief executive officer of Biocon Group as the Indian drugmaker looks to expand its place in emerging markets. (Biocon) ...
A corporate incentive program at Biocon’s Bengaluru campus has successfully moved over 1,500 staff to public transit, ...
Promoter Biocon Limited sold 80 lakh shares in Syngene International for an average price of Rs 857.68. via a bulk deal on ...
Biocon Electric has filed its DRHP with SEBI for a proposed IPO of up to 59 lakh shares, comprising a fresh issue and an ...
Biocon Electric Ltd IPO 1970 - Get Biocon Electric Ltd open and close date, listing date, price band, IPO lot size, allotment, subscription status, review, key insights, and much more only at Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results